Abstract
Nuclear factor E2-related factor 2 (Nrf2) is a critical regulator of cytoprotective gene expression. However, the role of this transcription factor in myocardiac cytoprotection against oxidative and electrophilic stress remains unknown. This study was undertaken to investigate if Nrf2 signaling could control the constitutive and inducible expression of antioxidants and phase 2 enzymes in primary cardiomyocytes as well as the susceptibility of these cells to oxidative and electrophilic injury. The basal expression of a series of antioxidants and phase 2 enzymes was significantly lower in cardiomyocytes from Nrf2−/− mice than those from wild-type littermates. Incubation of wild-type cardiomyocytes with 3H-1,2-dithiole-3-thione (D3T) led to significant induction of various antioxidants and phase 2 enzymes, including catalase, glutathione, glutathione peroxidase (GPx), glutathione reductase, glutathione S-transferase, NAD(P)H:quinone oxidoreductase 1, and heme oxygenase-1. The inducibility of the above cellular defenses except GPx by D3T was abolished in Nrf2−/− cardiomyocytes. As compared to wild-type cells, Nrf2−/− cardiomyocytes were much more susceptible to cell injury induced by H2O2, peroxynitrite, and 4-hydroxy-2-nonenal. Treatment of wild-type cardiomyocytes with D3T, which upregulated the cellular defenses, resulted in increased resistance to the above oxidant- and electrophile-induced cell injury, whereas D3T treatment of Nrf2−/− cardiomyocytes provided no cytoprotection. This study demonstrates that Nrf2 is an important factor in controlling both constitutive and inducible expression of a wide spectrum of antioxidants and phase 2 enzymes in cardiomyocytes and is responsible for protecting these cells against oxidative and electrophilic stress. These findings also implicate Nrf2 as an important signaling molecule for myocardiac cytoprotection.
Similar content being viewed by others
Abbreviations
- ARE:
-
Antioxidant response element
- CDNB:
-
1-chloro-2,4-dinitrobenzene
- D3T:
-
3H-1,2-dithiole-3-thione
- DCIP:
-
2,6-dichloroindophenol
- FBS:
-
Fetal bovine serum
- γGCL:
-
γ-Glutamylcysteine ligase
- GCLC:
-
γ-Glutamylcysteine ligase catalytic subunit
- GPx:
-
Glutathione peroxidase
- GR:
-
Glutathione reductase
- GSH:
-
Reduced glutathione
- GSSG:
-
Oxidized form of glutathione
- GST:
-
Glutathione S-transferase
- HNE:
-
4-hydroxy-2-nonenal
- HO-1:
-
Heme oxygenasse-1
- MTT:
-
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide
- NQO1:
-
NAD(P)H:quinone oxidoreductase 1
- Nrf2:
-
Nuclear factor E2-related factor 2
- PBS:
-
Phosphate buffered saline
- SIN-1:
-
3-morpholinosydnonimine
- RT-PCR:
-
Reverse transcriptase-polymerase chain reaction
- SOD:
-
Superoxide dismutase
References
McCord, J. M. (1985). Oxygen-derived free radicals in postischemic tissue injury. The New England Journal of Medicine, 312, 159–163.
Villamena, F. A., & Zweier, J. L. (2004). Detection of reactive oxygen, nitrogen species by EPR spin trapping. Antioxidants & Redox Signaling, 6, 619–629. doi:10.1089/152308604773934387.
Kutala, V. K., Khan, M., Angelos, M. G., & Kuppusamy, P. (2007). Role of oxygen in postischemic myocardial injury. Antioxidants & Redox Signaling, 9, 1193–206. doi:10.1089/ars.2007.1636.
Kang, Y. J. (2007). Antioxidant defense against anthracycline cardiotoxicity by metallothionein. Cardiovascular Toxicology, 7, 95–100 doi:10.1007/s12012-007-0007-3.
Salvemini, D., Wang, Z. Q., Zweier, J. L., Samouilov, A., Macarthur, H., Misko, T. P., Currie, M. G., Cuzzocrea, S., Sikorski, J. A., & Riley, D. P. (1999). A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science, 286, 304–306. doi:10.1126/science.286.5438.304.
Lefer, D. J., & Granger, N. (2000). Oxidative stress and cardiac disease. The American Journal of Medicine, 109, 315–323. doi:10.1016/S0002-9343(00)00467-8.
Steinberg, D. (2002). Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime. Nature Medicine, 8, 1211–1217. doi:10.1038/nm1102–1211.
Bolli, R., Becker, L., Gross, G., Mentzer, R. Jr., Balshaw, D., & Lathrop, D. A. (2004). NHLBI working group on the translation of therapies for protecting the heart from ischemia. Myocardial protection at a crossroads: The need for translation into clinical therapy. Circulation Research, 95, 125–134. doi:10.1161/01.RES.0000137171.97172.d7.
Lonn, E., Bosch, J., Yusuf, S., Sheridan, P., Pogue, J., Arnold, J. M., Ross, C., Arnold, A., Sleight, P., Probstfield, J., & Dagenais, G. R. (2005). HOPE and HOPE-TOO trial investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: A randomized controlled trial. Journal of the American Medical Association, 293, 1338–1347. doi:10.1001/jama.293.11.1338.
Bailey, D. M., Raman, S., McEneny, J., Young, I. S., Parham, K. L., Hullin, D. A., Davies, B., McKeeman, G., McCord, J. M., & Lewis, M. H. (2006). Vitamin C prophylaxis promotes oxidative lipid damage during surgical ischemia-reperfusion. Free Radical Biology & Medicine, 40, 591–600. doi:10.1016/j.freeradbiomed.2005.09.024.
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., Yamamoto, M., & Nabeshima, Y. (1997). An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochemical and Biophysical Research Communications, 236, 313–322. doi:10.1006/bbrc.1997.6943.
Motohashi, H., & Yamamoto, M. (2004). Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends in Molecular Medicine, 10, 549–557. doi:10.1016/j.molmed.2004.09.003.
Zhu, H., Zhang, L., Itoh, K., Yamamoto, M., Ross, D., Trush, M. A., Zweier, J. L., & Li, Y. (2006). Nrf2 controls bone marrow stromal cell susceptibility to oxidative and electrophilic stress. Free Radical Biology & Medicine, 41, 132–143. doi:10.1016/j.freeradbiomed.2006.03.020.
Spitz, D. R., & Oberley L. W. (1989). An assay for superoxide dismutase activity in mammalian tissue homogenates. Analytical Biochemistry, 179, 8–18. doi:10.1016/0003-2697(89)90192-9.
Aebi, H. (1984). Catalase in vitro. Methods in Enzymology, 105, 121–127. doi:10.1016/S0076-6879(84)05016-3.
Flohé L, & Günzler W. A. (1984). Assays of glutathione peroxidase. Methods in Enzymology, 105, 114–121. doi:10.1016/S0076–6879(84)05015-1.
Habig, W. H., Pabst, M. J., & Jakoby, W. B. (1974). Glutathione S-transferases: The first enzymatic step in mercapturic acid formation. The Journal of Biological Chemistry, 249, 7130–7139.
Naughton, P., Foresti, R., Bains, S. K., Hoque, M., Green, C. J., & Motterlini, R. (2002). Induction of heme oxygenase 1 by nitrosative stress. A role for nitroxyl anion. The Journal of Biological Chemistry, 277, 40666–40674. doi:10.1074/jbc.M203863200.
Zhu, H., Zhang, L., Trush, M. A., & Li, Y. (2007). Upregulation of endogenous glutathione system by 3H-1,2-dithiole-3-thione in pancreatic RINm5F beta-cells as a novel strategy for protecting against oxidative beta-cell injury. Free Radical Research, 41, 242–250. doi:10.1080/10715760601009586.
Jia, Z., Zhu, H., Misra, H. P., & Li, Y. (2008). Potent induction of total cellular GSH and NQO1 as well as mitochondrial GSH by 3H-1,2-dithiole-3-thione in SH-SY5Y neuroblastoma cells and primary human neurons: Protection against neurocytotoxicity elicited by dopamine, 6-hydroxydopamine, 4-hydroxy-2-nonenal, or hydrogen peroxide. Brain Research, 1197, 159–169. doi:10.1016/j.brainres.2007.12.044.
Halford, W. P., Falco, V. C., Gebhardt, B. M., & Carr, D. J. (1999). The inherent quantitative capacity of the reverse transcription-polymerase chain reaction. Analytical Biochemistry, 266, 181–191. doi:10.1006/abio.1998.2913.
Hayes, J. D., Flanagan, J. U., & Jowsey, I. R. (2005). Glutathione transferases. Annual Review of Pharmacology and Toxicology, 45, 51–88. doi:10.1146/annurev.pharmtox.45.120403.095857.
Abraham, N. G., & Kappas, A. (2005). Heme oxygenase and the cardiovascular-renal system. Free Radical Biology & Medicine, 39, 1–25. doi:10.1016/j.freeradbiomed.2005.03.010.
Ryter, S. W., Alam, J., & Choi, A. M. (2006). Heme oxygenase-1/carbon monoxide: From basic science to therapeutic applications. Physiological Research, 86, 583–650. doi:10.1152/physrev.00011.2005.
Szabó C, Ischiropoulos, H., & Radi, R. (2007) Peroxynitrite: Biochemistry, pathophysiology and development of therapeutics. Nature Reviews. Drug Discovery, 6, 662–680. doi:10.1038/nrd2222.
Lucas, D. T., & Szweda, L. I. (1998). Cardiac reperfusion injury: Aging, lipid peroxidation, and mitochondrial dysfunction. Proceedings of the National Academy of Sciences of the United States of America, 95, 510–514. doi:10.1073/pnas.95.2.510.
Shinmura, K., Bolli, R., Liu, S. Q., Tang, X. L., Kodani, E., Xuan, Y. T., Srivastava, S., & Bhatnagar A (2002). Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning. Circulation Research, 91, 240–246. doi:10.1161/01.RES.0000029970.97247.57.
Cho, H. Y., Reddy, S. P., Debiase, A., Yamamoto, M., & Kleeberger, S. R. (2005). Gene expression profiling of Nrf2-mediated protection against oxidative injury. Free Radical Biology & Medicine, 38, 325–343. doi:10.1016/j.freeradbiomed.2004.10.013.
Kwak, M. K., Wakabayashi, N., Itoh, K., Motohashi, H., Yamamoto, M., & Kensler, T. W. (2003). Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway: Identification of novel gene clusters for cell survival. The Journal of Biological Chemistry, 278, 8135–8145. doi:10.1074/jbc.M211898200.
Zhu, H., Itoh, K., Yamamoto, M., Zweier, J. L., & Li, Y. (2005). Role of Nrf2 signaling in regulation of antioxidants, phase 2 enzymes in cardiac fibroblasts: Protection against reactive oxygen and nitrogen species-induced cell injury. FEBS Letters, 579, 3029–3036. doi:10.1016/j.febslet.2005.04.058.
Anderson, M. E. (1998). Glutathione: An overview of biosynthesis and modulation. Chemico-Biological Interactions, 111–112, 1–14. doi:10.1016/S0009-2797(97)00146-4.
Banning, A., Deubel, S., Kluth, D., Zhou, Z., & Brigelius-Flohe, R. (2005). The GI-GPx gene is a target for Nrf2. Molecular and Cellular Biology, 25, 4914–4923. doi:10.1128/MCB.25.12.4914-4923.2005.
Li, Y., Lafuente, A., & Trush, M. A. (1994). Characterization of quinone reductase, glutathione and glutathione S-transferase in human myeloid cell lines: Induction by 1,2-dithiole-3-thione and effects on hydroquinone-induced cytotoxicity. Life Sciences, 54, 901–916. doi:10.1016/0024-3205(94)00626-1.
Ross, D. (2004). Quinone reductases multitasking in the metabolic world. Drug Metabolism Reviews, 36, 639–654. doi:10.1081/DMR-200033465.
Siegel, D., Gustafson D. L, Dehn, D. L., Han, J. Y., Boonchoong, P., Berliner, L. J., & Ross, D. (2004). NAD(P)H: Quinone oxidoreductase 1: Role as a superoxide scavenger. Molecular Pharmacology, 65, 1238–1247. doi:10.1124/mol.65.5.1238.
Zhu, H., Jia, Z., Mahaney, J. E., Ross, D., Misra, H. P., Trush, M. A., & Li, Y. (2007). The highly expressed and inducible endogenous NAD(P)H: Quinone oxidoreductase 1 in cardiovascular cells acts as a potential superoxide scavenger. Cardiovascular Toxicology, 7, 202–211. doi:10.1007/s12012-007-9001-z.
Asher, G., Lotem, J., Kama, R., Sachs, L., & Shaul, Y. (2002). NQO1 stabilizes p53 through a distinct pathway. Proceedings of the National Academy of Sciences of the United States of America, 99, 3099–3104. doi:10.1073/pnas.052706799.
Juan, S. H., Lee, T. S., Tseng, K. W., Liou, J. Y., Shyue, S. K., Wu, K. K., & Chau, L. Y. (2001). Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation, 104, 1519–1525. doi:10.1161/hc3801.095663.
Liu, X., Simpson, J. A., Brunt, K. R., Ward, C. A., Hall, S. R., Kinobe, R. T., Barrette, V., Tse, M. Y., Pang, S. C., Pachori, A. S., Dzau, V. J., Ogunyankin, K. O., & Melo, L. G. (2007). Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 yr after acute myocardial infarction. The American Journal of Physiology, 293, H48–H59.
Sies, H., Sharov, V. S., Klotz, L. O., & Briviba, K. (1997). Glutathione peroxidase protects against peroxynitrite-mediated oxidations: A new function for selenoproteins as peroxynitrite reductase. The Journal of Biological Chemistry, 272, 27812–27817. doi:10.1074/jbc.272.44.27812.
Xie, C., Lovell, M. A., Xiong, S., Kindy, M. S., Guo J.-T., Xie, J., Amaranth, V., Montine, T. J., & Markesbery, W. R. (2001). Expression of glutathione-S-transferase isozyme in the SY5Y neuroblastoma cell line increases resistance to oxidative stress. Free Radical Biology & Medicine, 31, 73–81. doi:10.1016/S0891-5849(01)00553-6.
Yang, Y., Cheng J.-Z., Singhal, S. S., Saini, M., Pandya, U., Awasthi, S., & Awasthi, Y. C. (2001). Role of glutathione S-transferases in protection against lipid peroxidation. The Journal of Biological Chemistry, 276, 19220–19230. doi:10.1074/jbc.M100551200.
Sayre, L. M., Lin, D., Yuan, Q., Zhu, X., & Tang, X. (2006). Protein adducts generated from products of lipid oxidation: Focus on HNE and one. Drug Metabolism Reviews, 38, 651–675. doi:10.1080/03602530600959508.
Cao, Z., Hardej, D., Trombetta, L. D., & Li, Y. (2003). The role of chemically induced glutathione and glutathione S-transferase in protecting against 4-hydroxy-2-nonenal-mediated cytotoxicity in vascular smooth muscle cells. Cardiovascular Toxicology, 3, 165–177. doi:10.1385/CT:3,2:165.
Li, Y., Cao, Z., Zhu, H., & Trush, M. A. (2005). Differential roles of 3H-1,2-dithiole-3-thione-induced glutathione, glutathione S-transferase and aldose reductase in protecting against 4-hydroxy-2-nonenal toxicity in cultured cardiomyocytes. Archives of Biochemistry and Biophysics, 439, 80–90. doi:10.1016/j.abb.2005.05.008.
Acknowledgments
This work was supported by grant R01HL71190 from the National Institutes of Health and a grant from Harvey Peters Research Foundation (YL).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Zhu, H., Jia, Z., Misra, B.R. et al. Nuclear Factor E2-Related Factor 2-Dependent Myocardiac Cytoprotection Against Oxidative and Electrophilic Stress. Cardiovasc Toxicol 8, 71–85 (2008). https://doi.org/10.1007/s12012-008-9016-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12012-008-9016-0